Yale University’s Corcept Therapeutics CORT Stock Holding History

Yale University’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-22,334	Closed	-$84K	–	7
2015 Q3	$84K	Buy	+22,334	New	+$113K	0.03%	8

Other funds holding CORT

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Yale University's CORT Position: Q4 2015 in Review

Yale University sold out of Corcept Therapeutics (CORT) in Q4 2015, closing a stake of 22,334 shares — an estimated $84K sold.

Yale University first reported a position in CORT in Q3 2015 and held it in 1 quarter. The position peaked at $84K in Q3 2015. 97 funds tracked by Wall St. Rank hold CORT as of Q4 2015.

Yale University reported no remaining Corcept Therapeutics position as of Q4 2015 after selling out during the quarter.
Yale University sold 22,334 Corcept Therapeutics shares in Q4 2015, an estimated $84K.
Yale University first reported a position in Corcept Therapeutics in Q3 2015 and held it in 1 quarter.
Yale University's Corcept Therapeutics position peaked at $84K in Q3 2015.
97 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2015.

Based on Yale University's 13F filing for Q4 2015, filed 11 Feb 2016.